Sixth ABC International Consensus Conference

The Sixth Advanced Breast Cancer International Consensus Conference takes place from 4-6 November 2021, in Lisbon, Portugal. It is the major international conference for Advanced Breast Cancer and a forum for sharing best clinical practices and the latest scientific updates in the field with the goal of improving outcomes for all patients with ABC. The Sixth ABC International Consensus Conference also aims to identify research priorities based on the most important areas of unmet needs, analyse and discuss available data to provide the most accurate management recommendations, as well as influence policy makers and funding bodies and ultimately improve standards of care, survival and quality of life. Research and education, with accurate usage of available knowledge, throughout the world, are key to achieve these goals. At the Sixth ABC International Consensus Conference, all topics will be presented from the perspective of a multidisciplinary and multi-professional approach, from basic research to clinical implementation. The conference will again close with a consensus session where discussion will focus on updating the ABC guidelines.

The ABC consensus conference started as a pioneering initiative of ESO in 2011, and from the willingness to change the abandonment feelings from ABC patients. Its primary goal is the development of international consensus guidelines for the management of advanced breast cancer patients. These guidelines are based on the most up-to date evidence and can be used to guide treatment decision making in many different health care settings globally, with the necessary adaptations due to different access to care. Throughout the years, these guidelines have been endorsed by several international and European organizations, and several organizations around the world have been adapting them to their country specific environment, particularly in terms of accessibility.

The last meeting, which took place in Lisbon, Portugal in November 2019, brought together 1.500 participants from 90 countries around the world, including health professionals, patient advocates and journalists. You can find out more at